Muge Ogrunc

Ageing is old-fashioned I Deeptech Laureate | @UNC PhD I En ce moment pArisenne

[Muge Ogrunc @mueg]

@KrizhanovskyLab @JuliaMMagdalena @amitmechaging @UriAlonWeizmann Congratulations to you and your team!

[Muge Ogrunc @mueg]

@DrSynbio So inspiring 🚀

[ISIDORe @isidore_eu]

We thank you all for the success of our users and members annual meetings #IsidoreYear2

@InsermTransfert @InfrafrontierEU @VetBioNet @infravec2 @EMBRC_EU @ERINHA_RI @EuroBioImaging @ECRIN_ERIC @EVAg_EU @EatrisEric @BBMRIERIC @ELIXIREurope @EuropeVaccine @instructhub

[ISIDORe @isidore_eu]

Müge Ogrunc ⁦@mueg⁩ presented WP6 (Isidore as a permanent instrument for the ERA) #IsidoreYear2 ⁦@institutpasteur⁩ ⁦@infravec2⁩

[Muge Ogrunc @mueg]

@AdamsBioAging @HanLi_Pasteur It was great listening to your talk @AdamsBioAging The Q&A session was remarkable. Thank you both 🙏

[Muge Ogrunc @mueg]

Also, back to square one with biomarkers in aging.

[Muge Ogrunc @mueg]

Today's STAT News explores Biological Clocks in the longevity field.
https://t.co/3elTJv0slu via @statnews

[Muge Ogrunc @mueg]

Accuracy and ethics are vital in commercialization. Collaboration is key, prioritizing prognostic health outcomes over chronological age estimators (which most of the current clocks reveal, anyway).#BiologicalClocks

[Muge Ogrunc @mueg]

Senescence: a dual-edged sword in cancer immunity. While senolytic therapies aim to clear senescent cells, biomarkers are the missing link for effective treatment. Let's bridge the gap for better outcomes. #Biomarkers #SenescenceTherapy #TumorImmunity

[Muge Ogrunc @mueg]

Exploring the frontier of senescence-targeted therapy reveals a critical gap: the absence of robust senescence biomarkers. In the intricate dance of tumor immunity, senescent cells hold sway, either fueling or quelling cancer growth. #SenescenceTherapy #TumorImmunity #Biomarkers

[Muge Ogrunc @mueg]

The dynamic nature of senescence in cancer demands biomarker-assisted strategies for precise therapy. Without these guides, the delicate balance within the tumor microenvironment remains elusive. #CancerResearch #Immunoediting #SenescenceTherapy

[Muge Ogrunc @mueg]

@CarstenSchulte4 @StrathBiomedEng Best of luck! Change is always good 😊

[Muge Ogrunc @mueg]

Starting my Thursday with a power-packed startup breakfast session fueled by caffeine! 💼 Always worth clearing my schedule to attend. Today, someone shared the sweetest compliment, saying my questions sparked new perspectives and deeper understanding. Made my day! #Grateful

[Muge Ogrunc @mueg]

@FdAdF66 Bienvenue à Paris, Fabrizio ! à trés vite..

[Muge Ogrunc @mueg]

🌟Recent article from the Doudna lab, showcasing the potential of CRISPR-Riboproteins and mRNA-based delivery systems in gene editing therapies. This can make a tangible difference by cell-type specific non-viral delivery of gene editing molecules! https://t.co/tPg3kOc9bd

[Muge Ogrunc @mueg]

Lessons learned: focus on growth, not just accolades. In a world obsessed with superficial recognition, let's champion ethical collaboration and fair credit. Remember, true success lies in the journey, not just the destination. #EthicalLeadership #GrowthMindset

[Muge Ogrunc @mueg]

Life, much like the scientific journey we've embarked on, presents us with an array of obstacles, roadblocks, and unforeseen hurdles. It's a reality I was reminded of while reading an old HBR article titled 'How to Respond When Someone Takes Credit for Your Work.'

[Muge Ogrunc @mueg]

Hello Tomorrow Global Summit 2024 started with amazing pitch sessions today. @hellotmrc

[Muge Ogrunc @mueg]

@KrizhanovskyLab So well-deserved

[Muge Ogrunc @mueg]

Thank you @fdadf66 for reuniting us. To many more years of great science and memories #fda20

[Fabrizio d'Adda di Fagagna @FdAdF66]

20 years have passed since I started my group in @IFOMresearch
This called for a celebration for past and present members. Amazingly, many overcame work, family or distance to gather in #Ortigia.
I am immensely grateful for having had the opportunity to work and learn from them.